P, H., J, B., V, C., & JM, B. (1998). UP 202-56, an adenosine analogue, selectively acts via A1 receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression. Pain, 75(2-3), 281. https://doi.org/10.1016/s0304-3959(98)00006-2
Chicago Style (17th ed.) CitationP, Honoré, Buritova J, Chapman V, and Besson JM. "UP 202-56, an Adenosine Analogue, Selectively Acts via A1 Receptors to Significantly Decrease Noxiously-evoked Spinal C-Fos Protein Expression." Pain 75, no. 2-3 (1998): 281. https://doi.org/10.1016/s0304-3959(98)00006-2.
MLA (9th ed.) CitationP, Honoré, et al. "UP 202-56, an Adenosine Analogue, Selectively Acts via A1 Receptors to Significantly Decrease Noxiously-evoked Spinal C-Fos Protein Expression." Pain, vol. 75, no. 2-3, 1998, p. 281, https://doi.org/10.1016/s0304-3959(98)00006-2.